NEW YORK (Reuters Health) – Social rather than disease factors are probably to blame for the lower survival rates among African Americans with advanced non-small-cell lung carcinoma (NSCLC) than in other racial groups.
Dr. A. William Blackstock, from Wake Forest University in Winston-Salem, North Carolina, and colleagues compared the outcomes of 46 African-American and 458 non-African-American patients with advanced NSCLC who were treated with similar systemic therapy regimens.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!